(Q53547774)

15 May 2018

title

HGF/SF up-regulates the expression of bone morphogenetic protein 7 in prostate cancer cells. (English)

1 reference

15 May 2018

1 reference

1

1 reference

15 May 2018

Wen G. Jiang

5

1 reference

15 May 2018

author name string

Jonathan M Lewis-Russell

2

1 reference

15 May 2018

Andrew J Sanders

3

1 reference

15 May 2018

Howard Kynaston

4

1 reference

15 May 2018

publication date

26 November 2007

1 reference

15 May 2018

published in

Urologic Oncology

1 reference

15 May 2018

volume

26

1 reference

15 May 2018

issue

2

1 reference

15 May 2018

page(s)

190-197

1 reference

15 May 2018

Hepatocyte growth factor, its receptor, and their potential value in cancer therapies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

The bone morphogenetic protein system in mammalian reproduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

The bone morphogenetic protein family and osteogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Bone morphogenetic protein signaling in joint homeostasis and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Signal transduction of bone morphogenetic protein receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

7 January 2021

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Bone morphogenetic protein-6 expression in normal and malignant prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Epigenetic regulation of human bone morphogenetic protein 6 gene expression in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Placental bone morphogenetic protein (PLAB) gene expression in normal, pre-malignant and malignant human prostate: relation to tumor development and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Expression of bone morphogenetic protein-7 (BMP-7) in human prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Expression of peroxisome-proliferator activated receptor-gamma (PPAR?) and the PPAR? co-activator, PGC-1, in human breast cancer correlates with clinical outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

A closed tube format for amplification and detection of DNA based on energy transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Prognostic Significance of Plasma Scatter Factor/Hepatocyte Growth Factor Levels in Patients with Metastatic Hormone- Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 150005/9480

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Hepatocyte growth factor is produced by blood and alveolar neutrophils in acute respiratory failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Overexpression and regulation of expression of scatter factor/hepatocyte growth factor in prostatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.03.027

10.1016/J.UROLONC.2007.03.027

7 January 2021

Identifiers

DOI

1 reference

15 May 2018

release_azx65ent7rcezkcvvykjmha3ra

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/azx65ent7rcezkcvvykjmha3ra

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

15 May 2018